Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KARMA-Dep Trial of adjunctive ketamine for major depression
2016-004764-18Phase 2Completed
- Sponsor
- St Patrick's Mental Health Services
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in major depressive disorder (MDD) comparing Ketamine adjunctive arm with Midazolam control arm (2 arms). Primary endpoints: Trial process outcomes and Safety and tolerability of repeated ketamine infusions versus midazolam. Started Nov 2016; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2016-004764-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004764-18.